Wouter Geurts,
Business Development Manager - FILMS ,
TEKNI-PLEX
Wouter Geurts (TekniPlex Healthcare) is a bio-engineer with additional degrees in materials engineering, business management and IP law. He has worked over 8 years for trade associations (EuPC, Agoria) of the plastics d composites industries industries in Brussels. Since 2021 he is taking the lead for the diagnostics market for TekniPlex, a supplier of COC- and COP-based solutions, high barrier film architectures and customized components for microfluidics, diagnostics, medical devices and pharmaceutical packaging. He is also following up with EuPC MedPharmplast and the Senior Executive Forum of the converter association in Brussels.
REACH Restriction Proposal of Fluoropolymers and all PFAS-Substances: What is Happening in Brussels, How Will it Impact Microfluidics, Diagnostics and What to Do?
Tuesday, 20 June 2023 at 14:30
Add to Calendar ▼2023-06-20 14:30:002023-06-20 15:30:00Europe/LondonREACH Restriction Proposal of Fluoropolymers and all PFAS-Substances: What is Happening in Brussels, How Will it Impact Microfluidics, Diagnostics and What to Do?Point-of-Care, Biosensors and Rapid Diagnostics Europe 2023 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
The purpose of the presentation is to provide a nutshell overview of what the current proposal is aiming at, what can be done (to respond to the open consultation by ECHA before it closes in September 2023 and to report uses of PFAS and fluoropolymers that are not yet listed, among them many which relate to microfluidics), and to present a roadmap on how this may impact the future of microfluidics – in essence – a roadmap.
What is happening now? While low-molecular PFAS are now being assessed by the Environmental Protection Agency in the USA, a much more significant legislative change is coming in Europe. The REACH restriction proposal will ban over 10000 substances that contain Carbon-fluor bonds, and it will impact future use of materials used in diagnostic assay development and microfluidics in Europe, for instance because it will ban the use of PTFE. This will impact the future use of fluoropolymers and fluorinated substances in assays on a short term. The restriction is expected to enter into force in 2025-2026.
Add to Calendar ▼2023-06-19 00:00:002023-06-20 00:00:00Europe/LondonPoint-of-Care, Biosensors and Rapid Diagnostics Europe 2023Point-of-Care, Biosensors and Rapid Diagnostics Europe 2023 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
Add to Calendar ▼2023-06-20 14:30:002023-06-20 15:30:00Europe/LondonREACH Restriction Proposal of Fluoropolymers and all PFAS-Substances: What is Happening in Brussels, How Will it Impact Microfluidics, Diagnostics and What to Do?Point-of-Care, Biosensors and Rapid Diagnostics Europe 2023 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
